FDA is criticised for poor oversight of drug companies' promotion of off-label drug use

被引:0
|
作者
Tanne, Janice Hopkins
机构
来源
BMJ-BRITISH MEDICAL JOURNAL | 2008年 / 337卷 / 7665期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [32] Off-Label Drug Use and Promotion: Balancing Public Health Goals and Commercial Speech
    Kesselheim, Aaron S.
    AMERICAN JOURNAL OF LAW & MEDICINE, 2011, 37 (2-3) : 225 - 257
  • [33] On-label and off-label drug use in the treatment of endometriosis
    Quaas, Alexander M.
    Weedin, Elizabeth A.
    Hansen, Karl R.
    FERTILITY AND STERILITY, 2015, 103 (03) : 612 - 625
  • [34] Should off-label drug use be off-the-table?
    Rivkees, Scott A.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2007, 20 (02): : 171 - 172
  • [35] Adverse drug reactions and off-label drug use in paediatric outpatients
    Horen, B
    Montastruc, JL
    Lapeyre-Mestre, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (06) : 665 - 670
  • [36] Freedom of Speech and the FDA's Regulation of Off-Label Drug Uses
    Rogers, Jacob
    GEORGE WASHINGTON LAW REVIEW, 2008, 76 (05) : 1429 - 1443
  • [37] Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing
    Kesselheim, Aaron S.
    Woloshin, Steven
    Lu, Zhigang
    Tessema, Frazer A.
    Ross, Kathryn M.
    Schwartz, Lisa M.
    JAMA INTERNAL MEDICINE, 2019, 179 (05) : 707 - 709
  • [38] Off-label drug in the newborn
    Cuzzolin, Laura
    JOURNAL OF PEDIATRIC AND NEONATAL INDIVIDUALIZED MEDICINE, 2014, 3 (02):
  • [39] Unlicensed and Off-Label Drug Use in ChildrenImplications for Safety
    Imti Choonara
    Sharon Conroy
    Drug Safety, 2002, 25 : 1 - 5
  • [40] Off-Label Use and Safety of Drug Use in Vascular Anomalies
    Kleiber, Niina
    Gariepy-Assal, Laurence
    Coulombe, Jerome
    Marcoux, Simon
    Essouri, Sandrine
    McCuaig, Catherine
    Powell, Julie
    Soulez, Gilles
    Dubois, Josee
    DERMATOLOGY, 2021, 237 (04) : 649 - 657